A US congressional commission is escalating its warning that the US could soon be eclipsed by China in biotech, after lawmakers took up some of

Thanks to CEPI, Moderna’s H5 bird flu vaccine can start a pivotal trial shelved after funding for the jab was pulled in the US by

The FDA placed a partial hold on Daiichi Sankyo and Merck’s Phase 3 study of a lung cancer drug after the companies paused enrollment for

Our latest crop of biofinancings has nine-figure rounds for Ambros, Atavistik, Orum, and Addition, with Link Cell and Aeovian also raising new funds.

J&J has claimed FDA approval for Rybrevant Faspro, a subcutaneous version of the lung cancer therapy central to its blockbuster hopes for the drug.